Insmed (INSM) Goodwill & Intangibles (2010 - 2026)
Insmed (INSM) recorded quarterly Goodwill & Intangibles of $231.7 million in Q1 2026, down 0.89% quarter-over-quarter from $233.8 million in Q4 2025, and up 70.23% on a YoY basis from $136.1 million in Q1 2025.
Insmed (INSM) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Insmed's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $231.7 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 70.23% year-over-year to $231.7 million; the TTM figure through Mar 2026 stood at $231.7 million (up 70.23% YoY), while the FY2025 annual figure was $233.8 million, up 20.03% from the prior year.
- Goodwill & Intangibles was $231.7 million for Q1 2026 at Insmed, down from $233.8 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $233.8 million in Q4 2025 to a low of $136.1 million in Q3 2023.
- Historically, Goodwill & Intangibles has averaged $194.7 million across 5 years, with a median of $202.3 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles surged 343.76% in 2022, then sank 33.97% in 2023.
- A 5-year view of Goodwill & Intangibles shows it stood at $204.9 million in 2022, then fell by 2.47% to $199.8 million in 2023, then dropped by 2.53% to $194.8 million in 2024, then rose by 20.03% to $233.8 million in 2025, then declined by 0.89% to $231.7 million in 2026.
- The last three Goodwill & Intangibles figures came in at $231.7 million (Q1 2026), $233.8 million (Q4 2025), and $220.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.68 Mn |
| Dec 31, 2025 | 233.76 Mn |
| Sep 30, 2025 | 220.69 Mn |
| Jun 30, 2025 | 192.24 Mn |
| Mar 31, 2025 | 136.10 Mn |
| Dec 31, 2024 | 194.75 Mn |
| Sep 30, 2024 | 136.10 Mn |
| Jun 30, 2024 | 197.28 Mn |
| Mar 31, 2024 | 198.54 Mn |
| Dec 31, 2023 | 199.80 Mn |
| Sep 30, 2023 | 136.10 Mn |
| Jun 30, 2023 | 202.33 Mn |
| Mar 31, 2023 | 203.60 Mn |
| Dec 31, 2022 | 204.87 Mn |
| Sep 30, 2022 | 206.12 Mn |
| Jun 30, 2022 | 207.39 Mn |
| Mar 31, 2022 | 208.66 Mn |
| Dec 31, 2021 | 209.92 Mn |
| Sep 30, 2021 | 211.18 Mn |
| Jun 30, 2021 | 46.74 Mn |